Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4924 On Other Exchanges
Symbol
Exchange
4924 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

ci:z holdings co ltd (4924) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CI:Z HOLDINGS CO LTD (4924)

Related News

No related news articles were found.

ci:z holdings co ltd (4924) Related Businessweek News

No Related Businessweek News Found

ci:z holdings co ltd (4924) Details

Ci:z Holdings Co.,Ltd. develops, manufactures, and sells cosmetics, health foods, beauty care products, and other products. The company offers skin care cosmetics, including low-stimulant cosmetics and anti-aging products for people of various ages; and supplements, food products, and other products that enhance health and beauty. It sells its products under the Dr.Ci:Labo, Labo Labo, and Genomer brand names through mail order, as well as through wholesale channels to drug stores, pharmacies, variety stores, cosmetics shops, and other retail stores; and operates Dr. Ci:Labo corners in directly managed stores, department stores, and shopping centers. Ci:z Holdings Co.,Ltd. was founded in 1999 and is headquartered in Tokyo, Japan.

693 Employees
Last Reported Date: 10/21/15
Founded in 1999

ci:z holdings co ltd (4924) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ci:z holdings co ltd (4924) Key Developments

Ci:z Holdings Co.,Ltd. to Report Q1, 2016 Results on Dec 10, 2015

Ci:z Holdings Co.,Ltd. announced that they will report Q1, 2016 results on Dec 10, 2015

Dr. Ci:Labo Co., Ltd., Annual General Meeting, Oct 21, 2015

Dr. Ci:Labo Co., Ltd., Annual General Meeting, Oct 21, 2015.

Dr. Ci:Labo Co., Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Full Year Ended July 31, 2015; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending July 31, 2016; Announces Dividend for the Year Ended July 31, 2015; Provides Dividend Guidance for the Year Ending July 31, 2016

Dr. Ci:Labo Co., Ltd. reported consolidated and non-consolidated earnings results for the full year ended July 31, 2015. For the year, on consolidated basis, the company reported net sales of JPY 37,656 million compared to JPY 35,916 million a year ago. Operating income was JPY 7,682 million compared to JPY 7,510 million a year ago. Ordinary income was JPY 7,778 million compared to JPY 7,569 million a year ago. Net income was JPY 4,940 million or JPY 100.46 per share compared to JPY 4,588 million or JPY 92.05 per share a year ago. Return on equity was 22.9% compared to 21.4% a year ago. Cash flow from operating activities was JPY 4,080 million compared to JPY 5,006 million a year ago. Net income before taxes was JPY 7.771 million compared to JPY 7.559 million a year ago. Acquisition of tangible fixed assets was of JPY 122.138 million compared to JPY 289.742 million a year ago. Acquisition of intangible fixed assets was of JPY 203.770 million compared to JPY 85.047 million a year ago. For the year, on non-consolidated basis, the company reported net sales of JPY 37,033 million compared to JPY 35,279 million a year ago. Operating income was JPY 7,338 million compared to JPY 7,595 million a year ago. Ordinary income was JPY 7,455 million compared to JPY 7,652 million a year ago. Net income was JPY 4,752 million or JPY 96.65 per share compared to JPY 4,686 million or JPY 94.01 per share a year ago. The company provided consolidated earnings guidance for the first half and full year of fiscal year ending July 31, 2016. For the first half ending January 31, 2016, the company expects net sales of JPY 18,850 million, operating income of JPY 3,100 million, ordinary income of JPY 3,100 million and net income of JPY 2,046 million or JPY 43.36 per share. For the full year, the company expects net sales of JPY 40,700 million, operating income of JPY 8,100 million, ordinary income of JPY 8,100 million and net income of JPY 5,250 million or JPY 111.26 per share. The company announced year end dividend of JPY 82 per share for the year ended July 31, 2015 compared to year end dividend of JPY 81 per share for the same period a year ago. The scheduled commencement date for payment of dividends is October 22, 2015. The company provided dividend guidance for the full year ending July 31, 2016. For the year end, the company expects to pay dividend of JPY 44 per share compared to JPY 82 per share for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4924:JP ¥1,864.00 JPY 0.00

4924 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4924.
View Industry Companies
 

Industry Analysis

4924

Industry Average

Valuation 4924 Industry Range
Price/Earnings 20.4x
Price/Sales 2.5x
Price/Book 4.9x
Price/Cash Flow 19.8x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CI:Z HOLDINGS CO LTD, please visit www.ci-labo.com/ir/e/index.html. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.